siRNA treatment decreases triglycerides in clients with uncommon problem

.RESEARCH FEATURE.19 September 2024.

Plozasiran lessened triglyceride levels by 80% and also decreased the risk of pancreatitis in people with consistent chylomicronemia, with or even without a hereditary medical diagnosis.